Super-enhancer-driven SLCO4A1-AS1 is a new biomarker and a promising therapeutic target in glioblastoma.

Sci Rep · 2025 · PMC11704019 · PMID 39762261

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

an increasing trendno p-value reported

Introduction Glioma is one of the most typical intracranial tumors 1 , 2 , with the occurrence of more than 10,000 new cases per year and an increasing trend year by year 3 .

also in 63,971 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.